Archive Newsletter
-
11.20.24 -- Regulatory Considerations For mRNA Platforms
11/20/2024
11/20/24 Advancing RNA Newsletter
-
11.13.24 -- Strategies To Address FDA CMC Trends For mRNA Therapies
11/13/2024
11/13/24 Advancing RNA Newsletter
-
11.06.24 -- Mastering mRNA Manufacturing: A Focus On Raw Materials & Supply Assurance
11/6/2024
11/06/24 Advancing RNA Newsletter
-
10.31.24 -- Navigate Regulatory Landscapes In Your mRNA Drug Development
10/31/2024
10/31/24 Advancing RNA Newsletter
-
10.31.24 -- Key Considerations For Aseptic Filling
10/31/2024
10/31/24 Advancing RNA Newsletter
-
10.30.24 -- A "Flight Plan" For Achieving These 3 mRNA Development Milestones
10/30/2024
10/30/24 Advancing RNA Newsletter
-
10.28.24 -- Nanoparticle Enabled Formulation And Drug Delivery Solutions
10/28/2024
10/28/24 Advancing RNA Newsletter
-
10.24.24 -- Are We Really Living In An mRNA Regulatory "Desert"?
10/24/2024
10/24/24 Advancing RNA Newsletter
-
10.17.24 -- Resources For Trouble-Free Validation
10/17/2024
10/17/24 Advancing RNA Newsletter
-
10.16.24 -- Shifting Scales: Considerations For Small-Scale mRNA Production
10/16/2024
10/16/24 Advancing RNA Newsletter
This website uses cookies to ensure you get the best experience on our website. Learn more